Mankind Pharma forays into the Agri-tech industry

New Delhi : Mankind Pharma has announced the launch of Mankind Agritech Pvt Ltd. The company has entered into the ever-growing Indian agri-Input segment to use technological innovations in the field and bring its expertise to Indian farmlands and the Indian agriculture consumers, respectively. The decision behind foraying into this division is to assist Indian farmers by providing new-age technologies and helping farmers for the betterment of the rural sector.

With the launch of Mankind Agritech, the company will be providing crop care solutions to Indian farmers, including weedicides, insecticides, fungicides, plant growth regulators and biologicals. Mankind Agritech will work towards food safety for the country . The company will invest in the new technological tools and aims to deliver the same to the farmers to support them.

Announcing the launch ,Mr Rajeev Juneja, Managing Director and Vice-Chairman, Mankind Pharma said, “We are happy to announce our launch in the Agritech domain with long-term investment plans with an initial 150 to 200 crore Capex infusion in the first two to three years. Mankind Agritech is committed to bring world-class crop protection technology to Indian farmers. Technology is playing a crucial role in ensuring the growth of the agriculture sector in India. Agritech has the potential to scale up the agricultural industry through technological intervention. If the farmers get the right products and tools they would be in a position to make an informed decision of using input and right technology. Mankind Agritech will ensure quality assurance to the farmers.

The new vertical will be headed by Mr Partha Sengupta, a veteran of the Indian agrochemical industry. Mr Partha Sengupta brings in a plethora of experience from the agrochemical industry with over three decades of experience in Sales and Marketing. Mr Sengupta was National Marketing Head and part of the Senior Leadership team at Dhanuka Agritech Limited overseeing Marketing operations in India, Bangladesh, and Nepal.

  • Related Posts

    Gaudium IVF launches AI powered Signature Labs; kicks off 19 centre expansion

    Gaudium IVF and Women Health Limited, India’s first publicly listed IVF chain, kicked off its first milestone in the company’s planned 19-centre expansion, as outlined in the growth roadmap shared…

    WHO releases updated guidelines on reducing the risk of cognitive decline and dementia

    The World Health Organization (WHO) released updated guidelines on reducing the risk of cognitive decline and dementia, providing countries with evidence-based recommendations to help prevent or delay the onset of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gaudium IVF launches AI powered Signature Labs; kicks off 19 centre expansion

    Gaudium IVF launches AI powered Signature Labs; kicks off 19 centre expansion

    WHO releases updated guidelines on reducing the risk of cognitive decline and dementia

    WHO releases updated guidelines on reducing the risk of cognitive decline and dementia

    Kerala researchers develop biosensor to measure snake venom for faster treatment

    Kerala researchers develop biosensor to measure snake venom for faster treatment

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Pharma pricing policy threatens innovation

    Pharma pricing policy threatens innovation

    16 empanelled hospitals face action after negligence in Ayushman Scheme

    16 empanelled hospitals face action after negligence in Ayushman Scheme